olprinone
Sign in to saveOlprinone (INN) is a cardiotonic agent. It has been marketed in Japan since 1996.
Research
188 papers- Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects.Cardiovascular drug reviews · 2002
- Systematic review and meta-analysis of the efficacy of olprinone and MEFV gene in treating heart failure.Cellular and molecular biology (Noisy-le-Grand, France) · 2023
- Effect of olprinone on ischemia-reperfusion induced myocardial injury in rats.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2019
- The effects of olprinone, a phosphodiesterase 3 inhibitor, on systemic and cerebral circulation.Current vascular pharmacology · 2006
- [Research status of olprinone in cardiovascular diseases].Zhonghua wei zhong bing ji jiu yi xue · 2018
via PubMed
Wikidata facts
- Mass
- 250.085
Show 3 more facts
- canonical SMILES
- CC1=C(C=C(C(=O)N1)C#N)C2=CN3C=CN=C3C=C2
- chemical formula
- C₁₄H₁₀N₄O
- Commons category
- Olprinone
Sources (2)
via Wikidata · CC0
~1 min read
Article
2 sectionsContents
- References
- External links
Olprinone (INN) is a cardiotonic agent. It has been marketed in Japan since 1996.
==References==
Connections
Japan
Country
medication
Entity
circulatory system
Entity
digital object identifier
Entity
chemical formula
Entity
molar mass
Entity
Q180686
Entity
CAS Registry Number
Entity
PubChem
Entity
intravenous infusion and defusion
Entity
simplified molecular input line entry specification
Entity
Q2311683
Entity
IUPAC nomenclature of chemistry
Entity
international nonproprietary name
Entity
route of administration
Entity
International Chemical Identifier
Entity
Jmol
Entity
Unique Ingredient Identifier
Entity
Eisai
Entity
regulation of therapeutic goods
Entity